Actively Recruiting
Use of a Combined Lactulose Hydrogen Breath Test and Abdominal X-ray to Diagnose Digestive Issues in Adults
Led by Klinik Arlesheim · Updated on 2025-08-28
500
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
Sponsors
K
Klinik Arlesheim
Lead Sponsor
K
Kantonsspital Baselland Bruderholz
Collaborating Sponsor
AI-Summary
What this Trial Is About
Hydrogen breath tests are used to detect carbohydrate malabsorption, measure the time it takes food to move through the intestines oro-caecal transit time or OCTT, link hydrogen gas increases with abdominal symptoms like bloating and diarrhea, and diagnose small intestinal bacterial overgrowth SIBO. Differentiating carbohydrate intolerance from SIBO is important because their treatments differ, with dietary changes used for intolerance and antibiotics for SIBO. Recent guidelines question the accuracy of hydrogen breath tests alone for diagnosing SIBO due to variable OCTT measurements, which can cause false positives. This study evaluates a new, simple, and affordable method combining a 20g lactulose hydrogen breath test with abdominal X-ray imaging to confirm OCTT and diagnose SIBO or carbohydrate intolerance. During the test, if hydrogen levels rise before the contrast agent appears in the cecum, SIBO is indicated. If the contrast agent is visible when hydrogen increases, OCTT is confirmed and symptoms after this point suggest carbohydrate intolerance. This approach aims to improve diagnosis without the higher costs and complexity of other imaging techniques. Participants included adults referred for hydrogen breath testing due to digestive symptoms with no organic disease found. During the test, breath hydrogen is monitored while abdominal X-rays are taken when hydrogen rises. Researchers will assess the safety and practicality of this combined test, measure agreement between observers analyzing OCTT, and determine the prevalence of food intolerance and SIBO among participants. The total assessment occurs within three hours during routine clinical care, using existing clinical data with patient consent.
CONDITIONS
Brief Title
Combined Lactulose H2-breath Test With Abdominal Imaging
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients referred for breath testing to assess digestive symptoms or maldigestion between 2020 and 2024
- Patients who have signed general consent allowing use of their clinical data for research
You will not qualify if you...
Research Team
M
Mark R Fox, MD
R
Raik Hartwig, Dipl. med.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here